Abstract

Objective: Nigrostriatal terminal losses are known to progress most rapidly in early-stage Parkinson disease (PD) and then plateau, whereas cortical pathology continues and may provide a better marker of PD progression in later stages. We investigated cortical gyrification indices in patients with different durations of PD, since cortical folding may capture complex processes involving transverse forces of neuronal sheets or underlying axonal connectivity. Methods: Longitudinal cohort structural MRI were obtained at baseline, 18 months, and 36 months from 70 patients with PD without dementia and 70 control participants. Cortical local gyrification index (LGI) was compared between controls and PD subgroups based upon duration of illness (DOI, <1 year [PD E, n 17], 1-5 years [PD M, n 19], >5 years [PD L, n 24]) and adjusted using false discovery rate. Associations between LGI and clinical measurements were assessed using multiple linear regression. Areas having significantly reduced LGI also were analyzed using baseline data from a newly established cohort (PD n 87, control n 66) to validate our findings. Results: In the longitudinal cohort, PD L had significantly reduced overall gyrification, and bilaterally in the inferior parietal, postcentral, precentral, superior frontal, and supramarginal areas, compared to controls (p < 0.05). Longitudinally, loss of gyrification was accelerated in PD M participants, compared to controls. LGI showed robust correlations with DOI and also was correlated with PD-related clinical measurements. Similar results were obtained in the validation sample. Conclusions: Loss of cortical gyrification may be accelerated within the first few years after PD diagnosis, and become particularly prominent in later stages. Thus, it may provide a metric for monitoring progression in vivo.

Original languageEnglish (US)
Pages (from-to)1143-1151
Number of pages9
JournalNeurology
Volume86
Issue number12
DOIs
StatePublished - Mar 22 2016

Fingerprint

Parkinson Disease
Dementia
Disease Progression
Linear Models
Pathology

All Science Journal Classification (ASJC) codes

  • Clinical Neurology

Cite this

@article{63869139a089405d8c85197252264b9e,
title = "Stage-dependent loss of cortical gyrification as Parkinson disease {"}unfolds{"}",
abstract = "Objective: Nigrostriatal terminal losses are known to progress most rapidly in early-stage Parkinson disease (PD) and then plateau, whereas cortical pathology continues and may provide a better marker of PD progression in later stages. We investigated cortical gyrification indices in patients with different durations of PD, since cortical folding may capture complex processes involving transverse forces of neuronal sheets or underlying axonal connectivity. Methods: Longitudinal cohort structural MRI were obtained at baseline, 18 months, and 36 months from 70 patients with PD without dementia and 70 control participants. Cortical local gyrification index (LGI) was compared between controls and PD subgroups based upon duration of illness (DOI, <1 year [PD E, n 17], 1-5 years [PD M, n 19], >5 years [PD L, n 24]) and adjusted using false discovery rate. Associations between LGI and clinical measurements were assessed using multiple linear regression. Areas having significantly reduced LGI also were analyzed using baseline data from a newly established cohort (PD n 87, control n 66) to validate our findings. Results: In the longitudinal cohort, PD L had significantly reduced overall gyrification, and bilaterally in the inferior parietal, postcentral, precentral, superior frontal, and supramarginal areas, compared to controls (p < 0.05). Longitudinally, loss of gyrification was accelerated in PD M participants, compared to controls. LGI showed robust correlations with DOI and also was correlated with PD-related clinical measurements. Similar results were obtained in the validation sample. Conclusions: Loss of cortical gyrification may be accelerated within the first few years after PD diagnosis, and become particularly prominent in later stages. Thus, it may provide a metric for monitoring progression in vivo.",
author = "Sterling, {Nicholas W.} and Ming Wang and Lijun Zhang and Lee, {Eun Young} and Guangwei Du and Mechelle Lewis and Martin Styner and Xuemei Huang",
year = "2016",
month = "3",
day = "22",
doi = "10.1212/WNL.0000000000002492",
language = "English (US)",
volume = "86",
pages = "1143--1151",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "12",

}

Stage-dependent loss of cortical gyrification as Parkinson disease "unfolds". / Sterling, Nicholas W.; Wang, Ming; Zhang, Lijun; Lee, Eun Young; Du, Guangwei; Lewis, Mechelle; Styner, Martin; Huang, Xuemei.

In: Neurology, Vol. 86, No. 12, 22.03.2016, p. 1143-1151.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Stage-dependent loss of cortical gyrification as Parkinson disease "unfolds"

AU - Sterling, Nicholas W.

AU - Wang, Ming

AU - Zhang, Lijun

AU - Lee, Eun Young

AU - Du, Guangwei

AU - Lewis, Mechelle

AU - Styner, Martin

AU - Huang, Xuemei

PY - 2016/3/22

Y1 - 2016/3/22

N2 - Objective: Nigrostriatal terminal losses are known to progress most rapidly in early-stage Parkinson disease (PD) and then plateau, whereas cortical pathology continues and may provide a better marker of PD progression in later stages. We investigated cortical gyrification indices in patients with different durations of PD, since cortical folding may capture complex processes involving transverse forces of neuronal sheets or underlying axonal connectivity. Methods: Longitudinal cohort structural MRI were obtained at baseline, 18 months, and 36 months from 70 patients with PD without dementia and 70 control participants. Cortical local gyrification index (LGI) was compared between controls and PD subgroups based upon duration of illness (DOI, <1 year [PD E, n 17], 1-5 years [PD M, n 19], >5 years [PD L, n 24]) and adjusted using false discovery rate. Associations between LGI and clinical measurements were assessed using multiple linear regression. Areas having significantly reduced LGI also were analyzed using baseline data from a newly established cohort (PD n 87, control n 66) to validate our findings. Results: In the longitudinal cohort, PD L had significantly reduced overall gyrification, and bilaterally in the inferior parietal, postcentral, precentral, superior frontal, and supramarginal areas, compared to controls (p < 0.05). Longitudinally, loss of gyrification was accelerated in PD M participants, compared to controls. LGI showed robust correlations with DOI and also was correlated with PD-related clinical measurements. Similar results were obtained in the validation sample. Conclusions: Loss of cortical gyrification may be accelerated within the first few years after PD diagnosis, and become particularly prominent in later stages. Thus, it may provide a metric for monitoring progression in vivo.

AB - Objective: Nigrostriatal terminal losses are known to progress most rapidly in early-stage Parkinson disease (PD) and then plateau, whereas cortical pathology continues and may provide a better marker of PD progression in later stages. We investigated cortical gyrification indices in patients with different durations of PD, since cortical folding may capture complex processes involving transverse forces of neuronal sheets or underlying axonal connectivity. Methods: Longitudinal cohort structural MRI were obtained at baseline, 18 months, and 36 months from 70 patients with PD without dementia and 70 control participants. Cortical local gyrification index (LGI) was compared between controls and PD subgroups based upon duration of illness (DOI, <1 year [PD E, n 17], 1-5 years [PD M, n 19], >5 years [PD L, n 24]) and adjusted using false discovery rate. Associations between LGI and clinical measurements were assessed using multiple linear regression. Areas having significantly reduced LGI also were analyzed using baseline data from a newly established cohort (PD n 87, control n 66) to validate our findings. Results: In the longitudinal cohort, PD L had significantly reduced overall gyrification, and bilaterally in the inferior parietal, postcentral, precentral, superior frontal, and supramarginal areas, compared to controls (p < 0.05). Longitudinally, loss of gyrification was accelerated in PD M participants, compared to controls. LGI showed robust correlations with DOI and also was correlated with PD-related clinical measurements. Similar results were obtained in the validation sample. Conclusions: Loss of cortical gyrification may be accelerated within the first few years after PD diagnosis, and become particularly prominent in later stages. Thus, it may provide a metric for monitoring progression in vivo.

UR - http://www.scopus.com/inward/record.url?scp=84961669816&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84961669816&partnerID=8YFLogxK

U2 - 10.1212/WNL.0000000000002492

DO - 10.1212/WNL.0000000000002492

M3 - Article

VL - 86

SP - 1143

EP - 1151

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 12

ER -